Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Sunday, April 20 2014 10:05pm ET - U.S. Markets Closed.
Industry Center
Industry Center > > Astellas Pharma US, Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Astellas Pharma US, Inc. Company Profile
Astellas Pharma US pilots pharma efforts that are outta this world. The company conducts research, development, and marketing efforts focused on therapeutic areas including cardiology, dermatology, immunology, infectious disease, neurology, oncology, urology, and metabolism. The company's primary products include transplant rejection therapy Prograf, overactive bladder treatment Vesicare, and vascular dilator Adenoscan, as well as antifungals Mycamine and AmBisome and enlarged prostate treatment Flomax. Astellas Pharma US, which is a subsidiary of Japan-based pharmaceutical firm Astellas Pharma, uses a direct sales force to market its products to consumers and health professionals in the US market.
Headlines for Astellas Pharma US, Inc.
Legal Settlement for Astellas Pharma
- Thu Apr 17
Astellas Named National Presenting Sponsor of the National Kidney Foundation Kidney Walk
- Tue Apr 15
Illinois-based Astellas to pay $7.3M settlement
- Wed Apr 16
Tokyo stocks up 0.23% by break
- Wed Mar 26
Tokyo stocks close up 0.37%
- Wed Mar 26
Contact Information
Address: 1 Astellas Way
Northbrook, IL 60062
Phone:847-317-8800
Fax:
Financial Highlights
Fiscal Year End:March
Key People
SVP Research and Development: William E. Fitzsimmons
President and CEO, Agensys: Sef Kurstjens
VP Urogenix: Karl Thor
Industry Information
Sector:
Industry:
Top Competitors
Johnson & Johnson
Pfizer Inc.
Roche Holding Ltd
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?